Concepedia
Statistics
Publications
6
Citations
118
H-Index
Active since
2003
Affiliations
Eli Lilly (Japan)(Current)
National Hospital Organization
Kindai University
Japanese Foundation For Cancer Research
Risa Sekiguchi is an author at Eli Lilly (Japan) specializing in chemotherapy, oncology, and medicine.
Publications per year
2003–2021
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer
Isamu Okamoto, Keisuke Aoe, Terufumi Kato et al. · Investigational New Drugs · 2013 · 41 citations
Medicine, Oncology, Pharmacology +13
A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma
Shinsuke Iida, Kazutaka Sunami, Hironobu Minami et al. · International Journal of Hematology · 2021 · 19 citations
Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors
Noboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada et al. · Cancer Chemotherapy and Pharmacology · 2013 · 17 citations
Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin Followed by Pemetrexed Consolidation Therapy in Japanese Patients With Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer
Seiji Niho, Kaoru Kubota, Keiji Nihei et al. · Clinical Lung Cancer · 2012 · 16 citations
Medicine, Oncology, Radiation Oncology +15
Bias correction of AIC in logistic regression models
Hirokazu Yanagihara, Risa Sekiguchi, Yasunori Fujikoshi · Journal of Statistical Planning and Inference · 2003 · 14 citations
Public Health, Computer Science, Item Response Theory +10
1–5 of 6